ABSTRACT
Síndrome do choro assimétrico é uma condição congênita secundária à hipoplasia ou ausência do músculo depressor do ângulo da boca. Trata-se de uma condição não tão incomum que pode cursar com assimetria facial ao chorar e sorrir, além de poder estar associadas a outras malformações congênitas. Crianças com essa deformidade podem sofrer dificuldades psicossociais e introversão. O arsenal terapêutico dessa condição já foi estudado e discutido na literatura com ênfase em abordagens cirúrgicas e invasivas. Relatamos aqui um caso de uma criança de 9 anos com essa síndrome, tratada, de forma menos invasiva, com toxina botulínica, com um bom resultado e satisfação.
Asymmetric crying face syndrome is a congenital condition secondary to hypoplasia or absence of the depressor muscle at the mouth angle. It is a common condition that presents with facial asymmetry while crying and smiling and may be associated with other congenital malformations. Children with this deformity may experience psychosocial difficulties and introversion. The therapeutic arsenal of this condition has already been studied and discussed in the literature with an emphasis on surgical and invasive approaches. We report here a case of a 9-year-old child with this syndrome, treated less invasively with botulinum toxin, with good result and satisfaction.
Subject(s)
Humans , Female , Child , History, 21st Century , Congenital Abnormalities , Botulinum Toxins, Type A , Facial Asymmetry , Facial Paralysis , Mouth Abnormalities , Congenital Abnormalities/genetics , Congenital Abnormalities/rehabilitation , Botulinum Toxins, Type A/adverse effects , Botulinum Toxins, Type A/drug effects , Botulinum Toxins, Type A/pharmacology , Facial Asymmetry/surgery , Facial Asymmetry/complications , Facial Asymmetry/drug therapy , Facial Paralysis/surgery , Facial Paralysis/complications , Facial Paralysis/congenital , Mouth Abnormalities/surgery , Mouth Abnormalities/diagnosis , Mouth Abnormalities/rehabilitationABSTRACT
BACKGROUND: The therapeutic uses of botulinum toxin have been expanding due to deeper knowledge of its molecular behaviour and different mechanisms of action. OBJECTIVE: To present suggested doses of Botox and Dysport for controlling the muscle hyperkinetic activity in facial palsy in the perioral area and to review other uses. METHODS: An extensive updated literature review on the success and limits of the botulinum neurotoxin (BoNT) therapeutic treatments. RESULTS/CONCLUSION: BoNT can be considered to be the preferred single method for many disorders; it has substituted for some conventional surgical methods and it can be associated with other therapies to increase overall treatment performance. Depending on the disorder, the lack of permanent effect causes no major inconvenience.